Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage

BACKGROUND: Patients with hematological malignancies often develop febrile neutropenia (FN) as a complication of cancer chemotherapy. Primary or secondary antifungal prophylaxis is recommended for patients with hematological malignancies to reduce the risk of invasive fungal infection (IFI). This st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gedik, Habip, Şimşek, Funda, Yıldırmak, Taner, Kantürk, Arzu, Arıca, Deniz, Aydın, Demet, Demirel, Naciye, Yokuş, Osman
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2014
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
https://ncbi.nlm.nih.gov/pubmed/24855365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S59683
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items